951 - 960 of 5832 Results
Title
Year
- A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD2023OPENTitle: A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBDJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00473-5Best OA location URL: https://www.nature.com/articles/s41531-023-00473-5.pdfCitation Count: 15
- The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease data2023OPENTitle: The IPDGC/GP2 Hackathon - an open science event for training in data science, genomics, and collaboration using Parkinson’s disease dataJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00472-6Best OA location URL: https://www.nature.com/articles/s41531-023-00472-6.pdfCitation Count: 5
- G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-22023OPENTitle: G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2Journal Name: BiomoleculesPublisher: MDPI AGVol: 13Issue #: 3Start Page: 473End Page: 473Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom13030473Best OA location URL: https://www.mdpi.com/2218-273X/13/3/473/pdf?version=1677847463Citation Count: 1
- Performance of machine learning algorithms for dementia assessment: impacts of language tasks, recording media, and modalities2023OPENTitle: Performance of machine learning algorithms for dementia assessment: impacts of language tasks, recording media, and modalitiesJournal Name: BMC Medical Informatics and Decision MakingPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12911-023-02122-6Best OA location URL: https://bmcmedinformdecismak.biomedcentral.com/counter/pdf/10.1186/s12911-023-02122-6Citation Count: 3
- Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease2023OPENTitle: Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 899End Page: 903Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29342Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29342Citation Count: 9
- B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression2023OPENTitle: B lymphocyte responses in Parkinson’s disease and their possible significance in disease progressionJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 5Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcad060Best OA location URL: https://academic.oup.com/braincomms/article-pdf/5/2/fcad060/49650847/fcad060.pdfCitation Count: 18
- Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment2023OPENTitle: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1069411Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1069411/pdfCitation Count: 17
- Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease2023OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 4
- Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s disease2023OPENTitle: Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 3Start Page: 112231End Page: 112231Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112231Best OA location URL: http://www.cell.com/article/S2211124723002425/pdfCitation Count: 31
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1